Amphotericin B
Showing 1 - 25 of >10,000
Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)
Active, not recruiting
- Bioequivalence
- Amphotericin B liposome for injection
- AmBisome
-
Haikou, Hainan, ChinaHaikou people's Hospital
Jun 12, 2023
Clinical Benefits of Different Formulations of Amphotericin B
Active, not recruiting
- Efficacy
- Safety
-
Jinan, Shandong, ChinaRui Yang,MD
Nov 3, 2023
The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal
Completed
- Fungal Infection
- Deoxycholic acid amphotericin B
-
Nanjing, Jiangsu, China
- +1 more
Nov 29, 2022
Cryptococcal Meningitis Trial in Kampala (MAT2203, Amphotericin B)
Active, not recruiting
- Cryptococcal Meningitis
- MAT2203
- Amphotericin B
-
Kampala, UgandaInfectious Disease Institute
Nov 16, 2022
Disseminated Histoplasma Capsulatum Infection, AIDS and Infections, Immunosuppression Trial (Liposomal Amphotericin B)
Not yet recruiting
- Disseminated Histoplasma Capsulatum Infection
- +3 more
- Liposomal Amphotericin B
- (no location specified)
Apr 12, 2023
Mucormycosis; Pulmonary (Etiology) Trial in Chandigarh (Posaconazole 600 mg followed by posaconazole 300 mg once daily,
Recruiting
- Mucormycosis; Pulmonary (Etiology)
- Posaconazole 600 mg followed by posaconazole 300 mg once daily
- Liposomal Amphotericin B
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Jul 19, 2022
Candidiasis, Chronic Mucocutaneous Trial run by the Matinas BioPharma Nanotechnologies, Inc. (Amphotericin B)
Completed
- Candidiasis, Chronic Mucocutaneous
- Amphotericin B
-
Bethesda, MarylandNational Institute of Allergy and Infectious Disease (NIAID)
Aug 17, 2022
Invasive Candidiasis, Invasive Aspergillosis Trial in Tianjin (Amphotericin B cholesteryl Sulfate Complex for Injection)
Not yet recruiting
- Invasive Candidiasis
- Invasive Aspergillosis
- Amphotericin B cholesteryl Sulfate Complex for Injection
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Jan 29, 2023
Cystic Fibrosis Trial in Christchurch (ABCI, Placebo)
Recruiting
- Cystic Fibrosis
- ABCI
- Placebo
-
Christchurch, New ZealandNew Zealand Clinical Research
Apr 4, 2023
Pulmonary Mucormycosis Trial in Chandigarh (Inhaled amp B deoxycholate+intravenous liposomal amp B, Intravenous liposomal
Completed
- Pulmonary Mucormycosis
- Inhaled amp B deoxycholate+intravenous liposomal amp B
- Intravenous liposomal amphotericin B alone
-
Chandigarh, IndiaPost graduate Institute medical education and research
Jan 24, 2022
Leishmaniasis Trial in Beer Sheva (Topical Amphotericin-B 0.4% liposomal gel)
Completed
- Leishmaniasis
- Topical Amphotericin-B 0.4% liposomal gel
-
Beer Sheva, IsraelSoroka University Medical Center
Mar 12, 2022
Cryptococcal Meningitis Trial (MAT2203, Amphotericin B)
Not yet recruiting
- Cryptococcal Meningitis
- MAT2203
- Amphotericin B
- (no location specified)
Sep 12, 2022
Amphotericin B With Flucytosine-Fluconazole Therapy for
Completed
- Cryptococcal Meningitis
- Amphotericin B 1 mg/kg 1 week & Flucytosine 100 mg/kg 1 week followed by Fluconazole 1200 mg/day 1 week
-
Yangon, MyanmarSpecialist hospital Mingalardon,Thakeyta and Waibargi,Yangon Gen
Apr 20, 2022
Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous Trial in Brasilia (Miltefosine 50mg, Pentoxifylline 400mg, Liposomal
Recruiting
- Leishmaniasis; Brazilian
- Leishmaniasis, Mucocutaneous
- Miltefosine 50mg
- +2 more
-
Brasilia, DF, BrazilHospital Universitario de Brasilia
Sep 13, 2023
Cryptococcal Meningitis Trial in Beijing (Amphotericin B Colloidal Dispersion, flucytosine, fluconazole)
Not yet recruiting
- Cryptococcal Meningitis
- Amphotericin B Colloidal Dispersion
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2022
Safety of ABCD in the Treatment of IFD
Recruiting
- Invasive Fungal Disease
- Amphotericin B colloidal dispersion（ABCD）
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 20, 2022
Neutropenia and Fever Trial (Amphotericin B liposomes)
Not yet recruiting
- Neutropenia and Fever
- Amphotericin B liposomes
- (no location specified)
Nov 1, 2021
Mucosal Leishmaniasis Trial in Santa Cruz de la Sierra (Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal
Recruiting
- Mucosal Leishmaniasis
- Group 1: Miltefosine
- +2 more
-
Santa Cruz de la Sierra, SC, BoliviaHospital Dermatologico de Jorochito
Jun 14, 2022
Fungal Infection, Onychomycosis, Fungus, Nail Trial in Bangkoknoi (amphotericin B in 30% DMSO, 30% DMSO)
Completed
- Fungal Infection
- +2 more
- amphotericin B in 30% DMSO
- 30% DMSO
-
Bangkoknoi, Bangkok, ThailandDepartment of Dermatology Siriraj Hospital
Sep 24, 2021
Bioequivalence Trial in Wuhan (Amphotericin B liposome for injection, AmBisome®)
Completed
- Bioequivalence
- Amphotericin B liposome for injection
- AmBisome®
-
Wuhan, Hubei, ChinaWuhan Medical Treatment Center
Jul 28, 2021
Meningitis, Cryptococcal, HIV Trial in United States (Itraconazole, Flucytosine, Fluconazole)
Completed
- Meningitis, Cryptococcal
- HIV Infections
- Itraconazole
- +3 more
-
Los Angeles, California
- +23 more
Oct 26, 2021
Histoplasmosis, AIDS Trial in Porto Alegre (single dose of L-AmB, 2 doses of L-AmB, 2 weeks of L-AmB)
Recruiting
- Histoplasmosis
- AIDS
- single dose of L-AmB
- +2 more
-
Porto Alegre, Rio Grande Do Sul, BrazilIrmandade da Santa Casa de Misericórdia de Porto Alegre
Jul 12, 2021
Cryptococcal Meningitis, HIV/AIDS Trial in Zhenjiang (Voriconazole 200mg, amphotericin B deoxycholate (0.4-0.5mg/kg/d),
Unknown status
- Cryptococcal Meningitis
- HIV/AIDS
- Voriconazole 200mg
- +2 more
-
Zhenjiang, Hangzhou, ChinaLijun Xu
Jan 31, 2021
Invasive Cryptococcosis Trial in Washington (ABLC)
Withdrawn
- Invasive Cryptococcosis
-
Washington, District of ColumbiaWashington Hospital Center
Feb 15, 2021
Candidiasis, Oral, HIV Trial in Puerto Rico, Tanzania, United States (Amphotericin B)
Completed
- Candidiasis, Oral
- HIV Infections
- Amphotericin B
-
Birmingham, Alabama
- +31 more
Oct 28, 2021